Schering back in good graces
Executive Summary
Schering-Plough completed all 212 significant steps and 30 validation actions required under its manufacturing consent decree by its deadline of Dec. 31, 2005. The goal was reached on time, as the company had anticipated (1"The Pink Sheet" Nov. 14, 2005, p. 28). The consent decree's obligations and requirements are subject to certification by an external third party and review and approval by FDA...
You may also be interested in...
Schering exits manufacturing consent decree
Schering-Plough's petition to dissolve the manufacturing consent decree it has been operating under since May 2002 is granted by U.S. District Court for New Jersey. The company completed the requisite 212 significant steps and 30 validation actions to comply with current good manufacturing practices at the end of 2005 (1"The Pink Sheet" Jan. 09, 2006, In Brief). FDA did not oppose the company's petition, according to Schering...
Schering To Wrap Up Consent Decree Major Steps, Validations By Year-End
Schering-Plough aims to complete certain major requirements under its manufacturing consent decree by the end of 2005, but intends to extend lessons learned from the process to other parts of its business
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.